AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...
Virtual screen of 10,000 proteins and 500 million compounds takes just a day, delivers 2 million small-molecule hits ...
Researchers in China have unveiled a new AI framework that could accelerate the discovery of new medicines. DrugCLIP can scan ...
Explore the impact of drug discovery automation in 2026, addressing complexity and improving decision-making across ...
A new AI breakthrough could slash the time it takes to discover life-saving medicines, according to researchers in ...
Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding ...
Figure 1. This figure depicts the four categories of protein druggability target screening tools discussed in this section, which include structure-based methods, sequence-based methods, machine ...
In drug discovery, virtual screening is a fast and cost-effective way of narrowing down vast chemical libraries to identify the most promising hits, reducing synthesis and testing requirements while ...
Oversubscribed GBP2.5M seed round led by Ahren Innovation Capital -- Strategic collaboration with o2h to progress drug discovery programme CAMBRIDGE, England--(BUSINESS WIRE)--January 12, 2026-- ...
This article is based on a poster originally authored by Daniel A. Barr, Mario Öeren, Peter A. Hunt, Jonathan D. Tyzack, Tomáš Chrien, Tamsin E. Mansley and Matthew D. Segall, which was presented at ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback